Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
479.80    4.90 (1.03%)
Bid:
479.80
Ask:
480.30
Spread: 0.50 (0.104%)
Market Cap: £5.98b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

Director/PDMR Shareholding

25 Oct 2021 15:05

RNS Number : 1766Q
Melrose Industries PLC
25 October 2021
 

25 October 2021

Melrose Industries PLC (the "Company")

Notification of Transactions of Persons

Discharging Managerial Responsibility in accordance with Article 19(1) of the Market Abuse

Regulation (2014/596/EU) ("MAR")

The Company announces that it was informed that on 22 October 2021, Charlotte Twyning, Non-executive Director, bought (i) 4,835 Ordinary Shares of 160/21 pence each in the Company ("Ordinary Shares") at a price of 161.07 pence per share, (ii) 1,264 Ordinary Shares at a price of 161.086 pence per share, (iii) 386 Ordinary Shares at a price of 161.09 pence per share, and (iv) 385 Ordinary Shares at a price of 161.1145 pence per share. Following this transaction, Ms Twyning now holds an interest of 70,246 Ordinary Shares, representing approximately 0.0016% of the issued share capital of the Company.

Enquiries:

Montfort Communications:

 

+44 (0) 20 3514 0897

 

Nick Miles, Charlotte McMullen

 

+44 (0) 7739 701 634 / +44 (0) 7921 881 800

 

 

 

Notification of Transactions of Persons

Discharging Managerial Responsibility in accordance with Article 19(1) of MAR

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name of natural person

Charlotte Twyning

2.

Reason for the notification

a)

Position / status

Non-executive Director (including 771 shares purchased on behalf of persons closely associated with her)

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer

a)

Full name of the entity

Melrose Industries PLC

b)

Legal Entity Identifier code

213800RGNXXZY2M7TR85

4.

Details of the transaction(s)

a)

Description of the financial instrument, type of instrument

Ordinary shares

b)

Identification Code

GB00BNR5MZ78

c)

Nature of the transaction

 Acquisition of ordinary shares of 160/21 pence each

d)

Currency

 GBP - Great British Pound

e)

Price(s) and volume(s)

 

Price

Volume

GBP 1.6107

4,835

GBP 1.61086

1,264

GBP 1.6109

386

GBP 1.611145

385

 

 

f)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

6,870

 

See 4(e)

g)

Date of the transaction

22 October 2021

h)

Place of the transaction

London Stock Exchange

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFEVIALEFIL
Date   Source Headline
2nd Oct 20237:00 amRNSShare Buyback Programme
25th Sep 20234:00 pmRNSHolding(s) in Company
18th Sep 20237:00 amRNSHolding(s) in Company
12th Sep 20237:00 amRNSGTF PW1100G update
7th Sep 20237:00 amRNSHalf-year Report
5th Sep 20234:00 pmRNSHolding(s) in Company
1st Sep 20234:30 pmRNSHolding(s) in Company
14th Aug 20231:23 pmRNSHolding(s) in Company
11th Aug 20233:30 pmRNSHolding(s) in Company
8th Aug 20234:00 pmRNSHolding(s) in Company
27th Jul 20234:30 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSDirectorate Change
19th Jun 20237:00 amRNSHolding(s) in Company
16th Jun 20234:45 pmRNSDirectorate Change
16th Jun 20231:30 pmRNSHolding(s) in Company
14th Jun 20236:19 pmRNSDirector/PDMR Shareholding
13th Jun 20234:50 pmRNSHolding(s) in Company
9th Jun 202310:00 amRNSHolding(s) in Company
8th Jun 20231:15 pmRNSResult of AGM
2nd Jun 202310:30 amRNSHolding(s) in Company
18th May 20235:15 pmRNSDirector/PDMR Shareholding
18th May 20234:02 pmRNSDirector/PDMR Shareholding
17th May 20231:00 pmRNSCapital Markets Event & New 2025 Guidance
15th May 20237:00 amRNSHolding(s) in Company
11th May 20235:15 pmRNSHolding(s) in Company
10th May 20237:00 amRNSTrading Update & New Guidance
5th May 20237:00 amRNSHolding(s) in Company
4th May 20237:00 amRNSHolding(s) in Company
27th Apr 202311:05 amRNSHolding(s) in Company
25th Apr 20234:35 pmRNSAnnual Report and Notice of Annual General Meeting
21st Apr 20234:00 pmRNSPost-Offer Undertakings Announcement
20th Apr 202312:20 pmRNSHolding(s) in Company
20th Apr 202311:55 amRNSDirector/PDMR Shareholding
20th Apr 20238:14 amRNSCompletion of the demerger of Dowlais
18th Apr 202311:30 amRNSDirector/PDMR Shareholding
18th Apr 20237:00 amRNSDirector Declaration
13th Apr 20235:30 pmRNSMelrose Industries
3rd Apr 20237:00 amRNSHolding(s) in Company
31st Mar 20234:00 pmRNSConfirmation of Post-Offer Undertakings
30th Mar 202311:45 amRNSResults of General Meeting
17th Mar 20235:15 pmRNSDirector Declaration
16th Mar 20232:00 pmRNSSecond Interim Dividend - Payment Date
6th Mar 20234:15 pmRNSHolding(s) in Company
3rd Mar 20234:10 pmRNSPublication of a Prospectus
3rd Mar 20234:00 pmRNSCirc re. Demerger Proposal
2nd Mar 20237:00 amRNSFinal Results
17th Feb 20235:00 pmRNSDirector Declaration
31st Jan 20239:45 amRNSHolding(s) in Company
20th Jan 202312:30 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSTrading Update & Capital Markets Event

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.